Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "First Phase 3 Results From CARTITUDE-4 - Cilta-Cel vs. Standard of Care (PVd or DPd) in Lenalidomide-Refractory MM"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Binod Dhakal
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Binod Dhakal
393 views
June 22, 2023
Comments 0
Login to view comments.
Click here to Login
Hematology